Kirsi Marja Oksman

Dr. Kirsi Marja Oksman

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2001 in Journal of Applied Microbiology
Verified
Journal Article
Closed access
PDF file
RPRiitta Puupponen-Pimiä
Riitta Puupponen-Pimiä
LNL. Nohynek
L. Nohynek
CMC. Meier
C. Meier
MKM. Kahkonen
M. Kahkonen
MHM. Heinonen
M. Heinonen
Kirsi Marja OksmanKirsi Marja Oksman
Kirsi Marja Oksman

7 April 2014 in Nature Communications
Verified
Journal Article
Open access
KMKarel Miettinen
Karel Miettinen
LDLemeng Dong
Lemeng Dong
NNNicolas Navrot
Nicolas Navrot
TSThomas Schneider
Thomas Schneider
VBVincent Burlat
Vincent Burlat
DWDanièle Werck-Reichhart
Danièle Werck-Reichhart
The (seco)iridoids and their derivatives, the monoterpenoid indole alkaloids (MIAs), form two large families of plant-derived bioactive compounds with a wide spectrum of high-value pharmacological and insect-repellent activities. Vinblastine and vincristine, MIAs used as anticancer drugs, are produced by Catharanthus roseus in extremely low levels, leading to high market prices and poor availability. Their biotechnological production is hampered by the fragmentary knowledge of their biosynthesis. Here we report the discovery of the last four missing steps of the (seco)iridoid biosynthesis pathway. Expression of the eight genes encoding this pathway, together with two genes boosting precursor formation and two downstream alkaloid biosynthesis genes, in an alternative plant host, allows the heterologous production of the complex MIA strictosidine. This confirms the functionality of all enzymes of the pathway and highlights their utility for synthetic biology programmes towards a sustainable biotechnological production of valuable (seco)iridoids and alkaloids with pharmaceutical and agricultural applications.

1 January 2006 in Nutrition and Cancer
Verified
Journal Article
Closed access
LNLiisa J. Nohynek
Liisa J. Nohynek
HAHanna-Leena Alakomi
Hanna-Leena Alakomi
MKMarja P Kähkönen
Marja P Kähkönen
Marina HeinonenMarina Heinonen
Marina Heinonen
IHIlkka M. Helander
Ilkka M. Helander
RPRiitta Puupponen-Pimiä
Riitta Puupponen-Pimiä
Antimicrobial activity and mechanisms of phenolic extracts of 12 Nordic berries were studied against selected human pathogenic microbes. The most sensitive bacteria on berry phenolics were Helicobacter pylori and Bacillus cereus. Campylobacter jejuni and Candida albicans were inhibited only with phenolic extracts of cloudberry, raspberry, and strawberry, which all were rich in ellagitannins. Cloudberry extract gave strong microbicidic effects on the basis of plate count with all studied strains. However, fluorescence staining of liquid cultures of virulent Salmonella showed viable cells not detectable by plate count adhering to cloudberry extract, whereas Staphylococcus aureus cells adhered to berry extracts were dead on the basis of their fluorescence and plate count. Phenolic extracts of cloudberry and raspberry disintegrated the outer membrane of examined Salmonella strains as indicated by 1-N-phenylnaphthylamine (NPN) uptake increase and analysis of liberation of [14C]galactose- lipopolysacc...

1 September 2004 in Trends in Plant Science
Verified
Journal Article
Closed access
Kirsi Marja OksmanKirsi Marja Oksman
Kirsi Marja Oksman
DIDirk Inzé
Dirk Inzé

28 April 2004 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
AAAnna-Marja Aura
Anna-Marja Aura
PMP. Martin-Lopez
P. Martin-Lopez
KOK. A. O’lEary
K. A. O’lEary
GWGary Williamson
Gary Williamson
Kirsi Marja OksmanKirsi Marja Oksman
Kirsi Marja Oksman
Celestino Santos-BuelgaCelestino Santos-Buelga
Celestino Santos-Buelga

1 June 2003 in Food Chemistry
Verified
Journal Article
Closed access
ANAnna Maria Nuutila
Anna Maria Nuutila
RPRiitta Puupponen-Pimiä
Riitta Puupponen-Pimiä
MAMarjukka Aarni
Marjukka Aarni
Kirsi Marja OksmanKirsi Marja Oksman
Kirsi Marja Oksman